Anti-FOXA2 antibody [EPR4466] (ab108422) is a rabbit monoclonal antibody detecting FOXA2 in Western Blot, IHC-P, ICC/IF. Suitable for Human, Mouse.
- Clone EPR4466 is the most cited clone to FOXA2
- Biophysical QC for unrivalled batch-batch consistency
- Over 100 publications
View Alternative Names
HNF3B, TCF3B, FOXA2, Hepatocyte nuclear factor 3-beta, HNF-3-beta, HNF-3B, Forkhead box protein A2, Transcription factor 3B, TCF-3B
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXA2 antibody [EPR4466] (AB108422)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human hepatocellular carcinoma tissue labelling FOXA2 with purified ab108422 at 1/500. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXA2 antibody [EPR4466] (AB108422)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human hepatocellular carcinoma tissue labelling FOXA2 with unpurified ab108422 at a 1/250 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Collaborator
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXA2 antibody [EPR4466] (AB108422)
Immunohistochemical analysis of Formalin/PFA-fixed paraffin-embedded human colon sections labelling FOXA2 with ab108422 at dilution of 1/500. The secondary antibody used was a polyclonal goat anti-rabbit biotin conjugated antibody at a dilution of 1/300. The sample was counterstained with hematoxylin. Antigen retrieval was heat mediated using citric acid.
This image is courtesy of Carl Hobbs, King's College London, United Kingdom
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-FOXA2 antibody [EPR4466] (AB108422)
Immunocytochemistry/Immunofluorescence analysis of HT-29 cells labelling FOXA2 with purified ab108422 at 1/300. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/500) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500) were also used.
-ve control 1 : primary antibody (1/300) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500).
-ve control 2 : ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXA2 antibody [EPR4466] (AB108422)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse liver tissue labelling FOXA2 with purified ab108422 at 1/500. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXA2 antibody [EPR4466] (AB108422)
ab108422 staining of FOXA2 in mouse brain (substantia nigra) tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Heat-mediated antigen retrieval was carried out using citric acid. Samples were incubated with primary antibody (1/500) for two hours at room temperature. A Biotin-conjugated goat anti-rabbit IgG polyclonal was used as the secondary antibody.
This image is courtesy of Carl Hobbs, King's College London, United Kingdom
- WB
Lab
Western blot - Anti-FOXA2 antibody [EPR4466] (AB108422)
Western blot : Anti-FOXA2 antibody [EPR4466] ab108422 staining at 1/1000 dilution, shown in green; [LOADING CONTROL] loading control staining at 1/[DILUTION] dilution, shown in magenta. A band was observed at 78 kDa. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-FOXA2 antibody [EPR4466] (ab108422) at 1/1000 dilution
Lane 1:
FOXA1 Recombinant Protein (GST Tag) at 0.1 µg
Lane 2:
FOXA2 Recombinant Protein (GST Tag) at 0.1 µg
Lane 3:
FOXA3 Recombinant Protein (GST Tag) at 0.1 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 78 kDa
false
- WB
Lab
Western blot - Anti-FOXA2 antibody [EPR4466] (AB108422)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-FOXA2 antibody [EPR4466] (ab108422) at 1/10000 dilution
All lanes:
Human colon cancer tissue lysate at 20 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 48 kDa
Observed band size: 52 kDa
false
- WB
Lab
Western blot - Anti-FOXA2 antibody [EPR4466] (AB108422)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-FOXA2 antibody [EPR4466] (ab108422) at 1/2000 dilution
All lanes:
Mouse lung tissue lysate at 20 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 48 kDa
Observed band size: 52 kDa
false
- WB
Unknown
Western blot - Anti-FOXA2 antibody [EPR4466] (AB108422)
All lanes:
Western blot - Anti-FOXA2 antibody [EPR4466] (ab108422) at 1/1000 dilution
Lane 1:
Human fetal colon tissue lysate at 10 µg
Lane 2:
HepG2 (human liver hepatocellular carcinoma cell line) cell lysate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 48 kDa
false
Related conjugates and formulations (8)
-
Anti-FOXA2 antibody [EPR4466] - BSA and Azide free
-
HRP Anti-FOXA2 antibody [EPR4466]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-FOXA2 antibody [EPR4466]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-FOXA2 antibody [EPR4466]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-FOXA2 antibody [EPR4466]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-FOXA2 antibody [EPR4466]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-FOXA2 antibody [EPR4466]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-FOXA2 antibody [EPR4466]
Reactivity data
Product details
Anti-FOXA2 antibody [EPR4466] (ab108422) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-P, WB in human, mouse samples.
Anti-FOXA2 antibody [EPR4466] (ab108422) has been cited over 104 times in peer reviewed journals and is trusted by the scientific community.
Abcams high quality manufacturing and validation processes ensure Anti-FOXA2 antibody [EPR4466] (ab108422) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-FOXA2 antibody [EPR4466] (ab108422) has 11 independent reviews from customers.
Anti-FOXA2 antibody [EPR4466] (ab108422) specifically detects FOXA2 (UniProt ID: Q9Y261; Molecular weight: 48kDa) and is sold in 100 uL and 1 mL selling sizes.
Conjugation-ready, carrier free format available for antibody clone EPR4466 - ab2281.
Antibody clone EPR4466 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, HRP, Alexa Fluor® 594, Alexa Fluor® 568, Alexa Fluor® 555, Alexa Fluor® 75 (ab193864, ab193879, ab19388, ab311752, ab31332, ab313233, ab3292).
FOXA2 is a pivotal transcription factor involved in the regulation of liver development and lung development. Research has shown that FOXA2 plays a significant role in various cancers, including liver and lung cancers. Understanding FOXA2's function can provide insights into developmental biology and potential therapeutic targets for cancer treatment.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FOXA2 influences important processes in embryonic development and organogenesis. It does not typically act as part of a larger complex but independently binds to DNA enabling the transcription of target genes. FOXA2 affects liver function by regulating genes involved in glucose and lipid metabolism and it also plays a part in the differentiation of cells in development stages.
Pathways
FOXA2 operates within pathways like the insulin signaling pathway and the Wnt signaling pathway. It collaborates with other transcription factors like FOXA1 and FOXA3 to maintain metabolic homeostasis. In the Wnt pathway FOXA2 impacts cell fate decisions essential for embryonic patterning and development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (150)
Recent publications for all applications. Explore the full list and refine your search
Journal of respiratory biology and translational medicine 2: PubMed41049046
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 17: PubMed40723267
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 13: PubMed40722696
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature genetics 57:1966-1980 PubMed40691407
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biology 14: PubMed40563838
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4865 PubMed40419484
2025
Applications
Unspecified application
Species
Unspecified reactive species
JDS communications 6:250-255 PubMed40405988
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica communications 13:108 PubMed40390134
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2025:8953305 PubMed40313860
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 82:109 PubMed40074868
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com